Fluorescence imaging-guided cancer photothermal therapy using polydopamine and graphene quantum dot-capped Prussian blue nanocubes. Issue 15 (24th February 2021)

• Record Type: Journal Article
• Authors: Wang, Meng; Li, Baolong; Du, Yu; Bu, Huimin; Tang, Yanyan; Huang, Qingli
• Is Part Of: RSC advances. Volume 11:Issue 15(2021)
• Page Start: 8420
• Page End: 8429
• Publication Date: 2021-02-24
• Subjects: Chemistry -- Periodicals; 540.5
• DOI: 10.1039/d0ra10491d
• Languages: English
• ISSNs: 2046-2069

Abstract

Abstract : Polydopamine and graphene quantum dot-capped Prussian blue nanocubes with fluorescence and enhanced photothermal conversion properties were prepared, and have been successfully used for the fluorescence imaging-guided photothermal therapy of tumors. Abstract : In recent years, imaging-guided photothermal tumor ablation has attracted intense research interest as one of the most exciting strategies for cancer treatment. Herein, we prepared polydopamine and graphene quantum dot-capped Prussian blue nanocubes (PB@PDA@GQDs, PBPGs) with high photothermal conversion efficiency and excellent fluorescence performance for imaging-guided cancer treatment. Transmission electron microscopy (TEM), UV-vis absorption spectroscopy (UV-vis), fluorescence spectroscopy, and X-ray photoelectron spectroscopy (XPS) were employed to characterize their morphology and structures. The photothermal conversion efficiency and therapeutic effect were evaluated in vitro and in vivo . Results revealed that this nanoagent had excellent biocompatibility and enhanced the photothermal effect compared to blue nanocubes (PBs) and polydopamine-capped Prussian blue nanocubes (PB@PDA, PBPs). Therefore, our study may open a new path for the production of PB-based nanocomposites as theranostic nanoagents for imaging-guided photothermal cancer treatment.